Liabilities / Assets
30th percentile
Higher debt load relative to assets than 30% of similar nonprofits.
990 • Fiscal year 2022 • EIN 20-1896813
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
30th percentile
Higher debt load relative to assets than 30% of similar nonprofits.
Liabilities / Revenue
35th percentile
Higher debt load relative to revenue than 35% of similar nonprofits.
Net Margin
35th percentile
Higher net margin than 35% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
48th percentile
Faster asset growth than 48% of similar nonprofits.
Revenue Growth
25th percentile
Faster revenue growth than 25% of similar nonprofits.
Assets
Up$7,612,511
Up $12,438 (+0.2%) from 2021
Net Assets
Up$7,354,976
Up $22,677 (+0.3%) from 2021
Liabilities
Down$257,535
Down $10,239 (-3.8%) from 2021
Revenue
Down$3,148,339
Down $397,489 (-11%) from 2021
Expenses
Up$3,131,159
Up $64,940 (+2.1%) from 2021
Net Income
Down$17,180
Down $462,429 (-96%) from 2021
This 2022 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To be the preeminent source of medical-grade porcine clinically tissue utilized to cure diseases, with the primary commitment to diabetes.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2022 • Form 990Summary only. Only limited summary data is available for this year.